KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Asset Utilization Ratio: 2019-2025

Historic Asset Utilization Ratio for Castle Biosciences (CSTL) over the last 6 years, with Sep 2025 value amounting to 0.62.

  • Castle Biosciences' Asset Utilization Ratio fell 0.36% to 0.62 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.62, marking a year-over-year decrease of 0.36%. This contributed to the annual value of 0.67 for FY2024, which is 38.21% up from last year.
  • Per Castle Biosciences' latest filing, its Asset Utilization Ratio stood at 0.62 for Q3 2025, which was down 6.26% from 0.66 recorded in Q2 2025.
  • In the past 5 years, Castle Biosciences' Asset Utilization Ratio registered a high of 0.67 during Q1 2025, and its lowest value of 0.16 during Q1 2021.
  • Its 3-year average for Asset Utilization Ratio is 0.55, with a median of 0.61 in 2024.
  • In the last 5 years, Castle Biosciences' Asset Utilization Ratio slumped by 69.24% in 2021 and then spiked by 65.04% in 2023.
  • Quarterly analysis of 5 years shows Castle Biosciences' Asset Utilization Ratio stood at 0.21 in 2021, then surged by 44.23% to 0.30 in 2022, then surged by 63.23% to 0.49 in 2023, then increased by 28.49% to 0.64 in 2024, then declined by 0.36% to 0.62 in 2025.
  • Its last three reported values are 0.62 in Q3 2025, 0.66 for Q2 2025, and 0.67 during Q1 2025.